Ante Karoglan

2.0k citations
8 papers · 187 indexed · h-index 4
Topics
Dermatology and Skin Diseases (5 papers)Acne and Rosacea Treatments and Effects (2 papers)Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (1 paper)
Partner nations
GermanySpainNetherlands

In The Last Decade

Ante Karoglan

5 papers receiving 179 citations

Peers

Ante Karoglan
Comparison fields: 5 of 68
  • Dermatology 83
  • Oncology 59
  • Artificial Intelligence 59
  • Epidemiology 38
  • Molecular Biology 24
Replace Kayo Harada with:
Kayo Harada Japan
Sunil Kumar Singh India
Alan Watson Australia
Alexander J. Stratigos Greece
Zaaima AL-Jabri Oman
Morgan Essex Germany
Derek Reiman United States
Antony Hardjojo Singapore
G.W. Jung Canada
Síona Ní Raghallaigh Ireland
Ante Karoglan relative to Kayo Harada Japan Kayo Harada's profile →
Citations per field
00.5×6.6×
Kayo Harada · 1×
Citations per year

Countries citing papers authored by Ante Karoglan

Since Specialization
Citations

This map shows the geographic impact of Ante Karoglan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ante Karoglan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ante Karoglan more than expected).

Fields of papers citing papers by Ante Karoglan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ante Karoglan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ante Karoglan. The network helps show where Ante Karoglan may publish in the future.

Co-authorship network of co-authors of Ante Karoglan

This figure shows the co-authorship network connecting the top 25 collaborators of Ante Karoglan. A scholar is included among the top collaborators of Ante Karoglan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ante Karoglan. Ante Karoglan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 0
2 0
3 65
4 1
5 31
6 80
7 0
8 10

About Ante Karoglan

Ante Karoglan is a scholar working on Dermatology, Sensory Systems and Pharmacy, having authored 8 papers that have together received 187 indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (5 papers), Acne and Rosacea Treatments and Effects (2 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (1 paper). The work is most often cited by research in Health Informatics (13 citations), Dermatology (83 citations) and Oncology (59 citations). Ante Karoglan has collaborated with scholars based in Germany, Spain and Netherlands. Frequent co-authors include Marc Güell, Bernhard Paetzold, Chris Callewaert, Alexander Enk, Dirk Schadendorf, Titus J. Brinker, Joachim Klode, Christof von Kalle, Carola Berking and Sebastian Haferkamp. Their work appears in journals such as Scientific Reports, European Journal of Cancer and Journal of Medical Internet Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026